| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 12/18/2008 | WO2008152064A1 Compositions and uses comprising a retinoid compound, an anti-irritant compound and benzoyl peroxide in acne |
| 12/18/2008 | WO2008151428A1 Novel compositions for modulating mrna translation |
| 12/18/2008 | WO2008151415A1 Combination for treatment of diabetes mellitus |
| 12/18/2008 | WO2008129270A3 Compositions comprising anti-inflammatory compounds |
| 12/18/2008 | WO2008121467A3 Combination therapy for treating cancer |
| 12/18/2008 | WO2008118691A3 Method of preparing an immunologically-active adjuvant-bound dried vaccine composition |
| 12/18/2008 | WO2008006106A3 Methods for preventing, postponing or improving the outcome of invasive spinal procedures |
| 12/18/2008 | WO2007100795A3 Combinations comprising a histone deacetylase inhibiting agent and a nuclear hormone receptor ligand for treating cardiovascular conditions |
| 12/18/2008 | US20080312417 Ucp5 |
| 12/18/2008 | US20080312410 Cysteine-containing peptide tag for site-specific conjugation of proteins |
| 12/18/2008 | US20080312267 Diagnosis and Treatment of Diseases Arising from Defects in the Tuberous Sclerosis Pathway |
| 12/18/2008 | US20080312266 Steroidal Compounds For Inhibiting Steroid Sulphatase |
| 12/18/2008 | US20080312242 7-aryl-3, 9-diazabicyclo(3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases |
| 12/18/2008 | US20080312210 Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure |
| 12/18/2008 | US20080312142 Composition for Increasing Body Height |
| 12/18/2008 | US20080311608 Antagonist of the oncogenic activity of the protein MDM2, and use thereof in the treatment of cancers |
| 12/18/2008 | US20080311199 Tamper-resistant oral opioid agonist formulations |
| 12/18/2008 | US20080311198 Tamper-resistant oral opioid agonist formulations |
| 12/18/2008 | US20080311188 Solid pharmaceutical compositions comprising a sip receptor agonist and a sugar alcohol |
| 12/18/2008 | US20080311184 Method for developing, testing, and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates |
| 12/18/2008 | US20080311126 Antisense Oligonucleotides Directed to Ribonucleotide Reducatase R2 and Uses Thereof in Combination Therapies for the Treatment of Cancer |
| 12/18/2008 | US20080311118 Vascular endothelial cell growth factor antagonists and uses thereof |
| 12/18/2008 | US20080311095 Methods and compositions for increased transgene expression |
| 12/18/2008 | US20080311079 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 12/18/2008 | US20080311073 Ilt3 Polypeptides and Uses Thereof |
| 12/18/2008 | DE60224400T2 Hepatitis c virus polymerase inhibitoren mit heterobicylischer struktur Hepatitis C virus polymerase inhibitors with heterobicylischer structure |
| 12/18/2008 | CA2690874A1 Improvements in and relating to mammalian reproduction |
| 12/18/2008 | CA2689662A1 Compositions and uses comprising a retinoid compound, an anti-irritant compound and benzoyl peroxide in acne |
| 12/18/2008 | CA2689592A1 Composition and uses of a retinoid, an anti-irritant compound and benzoyl peroxide, in acne |
| 12/17/2008 | EP2003130A2 Novel pyridine derivative having anti-helicobacter pylori activity |
| 12/17/2008 | EP2002846A2 Combination therapy using an IL-1 inhibitor for treating IL-1 mediated diseases |
| 12/17/2008 | EP2002845A2 Combinations comprising antimuscarinic agents and corticosteroids |
| 12/17/2008 | EP2002844A2 Combinations comprising antimuscarininc agents and beta-adrenergic agonists |
| 12/17/2008 | EP2002843A2 Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
| 12/17/2008 | EP2002839A1 Folic acid-containing pharmaceutical compositions, and related methods and delivery systems |
| 12/17/2008 | EP2002827A2 Methods and compositions for control of bone formation via modulation of sympathetic tone |
| 12/17/2008 | EP2001512A2 Use of the staudinger ligation in in vivo assembly of a biologically active compound |
| 12/17/2008 | EP2001511A1 Adenosine a2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders |
| 12/17/2008 | EP2001454A2 Use of at least one cytosolic phospholipase a2 inhibitor as a medicine for symptomatic treatment of mucoviscidosis |
| 12/17/2008 | EP2001438A2 Stable formulations, and methods of their preparation and use |
| 12/17/2008 | EP2001400A2 Oral formulations of glycyl-2-methylprolyl-glutamate |
| 12/17/2008 | EP1763369B1 Combinations comprising antimuscarinic agents and corticosteroids |
| 12/17/2008 | EP1722780A4 A method of preventing or treating glaucoma |
| 12/17/2008 | EP1536778B1 Proteins binding to cross-beta structure comprising amyloid and methods for modulation of the cross-beta structure, its formation and its associated toxicity |
| 12/17/2008 | EP1448186B1 Medicament for the treatment of viral skin and tumour diseases |
| 12/17/2008 | EP1425001B1 Phenethanolamine derivatives for treatment of respiratory diseases |
| 12/17/2008 | EP1007696B1 Il-13 receptor specific chimeric proteins and uses thereof |
| 12/17/2008 | EP0966297B1 Regulation of gastrointestinal motility |
| 12/17/2008 | CN101325974A Adenosine A2A receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders |
| 12/17/2008 | CN101325973A Use of oligouronates for treating mucus hyperviscosity |
| 12/17/2008 | CN101322848A Composition for gastroscopy and preparation thereof |
| 12/17/2008 | CN101322708A Extended release oral dosage composition |
| 12/17/2008 | CN101322707A Pharmaceutical composition containing histone deacetylase inhibitor |
| 12/17/2008 | CN101322690A Stable medicament lipid complexes |
| 12/17/2008 | CN100443469C 病毒聚合酶抑制剂 Viral polymerase inhibitors |
| 12/17/2008 | CN100443119C Inhalation of nitric oxide |
| 12/16/2008 | US7465734 Detecting potential therapeutic agent |
| 12/16/2008 | US7465582 expression of Nurr1 above basal levels in neural stem cells or neural progenitor cells increases the proportion of the cells which differentiate toward a neural fate |
| 12/16/2008 | US7465553 Psoriasin expression by breast epithelial cells |
| 12/16/2008 | US7465549 incubating SV2 protein or fragment with levetiracetam or an analog or derivative thereof and a potential binding partner and determining if the potential binding partner modulates the binding of levetiracetam to the SV2 protein |
| 12/16/2008 | US7465445 Methods of preventing or treating graft versus host reaction by administering an antibody or portion thereof that binds to AILIM |
| 12/16/2008 | US7465444 Methods of suppressing or treating an inflammatory bowel disease by administering an antibody or portion thereof that binds to AILIM |
| 12/16/2008 | US7465443 Acellular antibordetella vaccine |
| 12/16/2008 | US7465441 Using interleukins, immunoglobulin fusion; genetic engineering; signaling |
| 12/16/2008 | US7465437 Delivery of anti-migraine compounds through an inhalation route |
| 12/16/2008 | US7465436 Aerosol for delivery of benzotropine, pergolide, amantadine, deprenyl, or ropinerole, formed by vaporizing the drug that is coated on a solid support and condensing the vapor to form particles containing least 10 % by weight of the drug and less than 5 % by weight of degradation products |
| 12/16/2008 | US7465435 Delivery of beta-blockers through an inhalation route |
| 12/16/2008 | CA2395129C Process for producing nanometer particles by fluid bed spray-drying |
| 12/16/2008 | CA2328411C Glucocorticoid receptor antagonists for the treatment of dementia |
| 12/16/2008 | CA2294913C Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroxamic acid derivative |
| 12/11/2008 | WO2008150431A1 Il- 18 and protein kinase r inhibition for the treatment of copd |
| 12/11/2008 | WO2008150368A1 Cd34 stem cell-related methods and compositions |
| 12/11/2008 | WO2008150025A1 Novel bone mass increasing agent |
| 12/11/2008 | WO2008149980A1 Fibrosis inhibitor |
| 12/11/2008 | WO2008149971A1 Therapeutic or prophylactic agent for cerebral aneurysm |
| 12/11/2008 | WO2008149521A1 Therapeutic agent for cancer, and method for treatment of cancer |
| 12/11/2008 | WO2008148873A2 Hydroxyproline compositions and uses thereof |
| 12/11/2008 | WO2008148572A1 Anti-inflammatory active ingredient combination for the treatment of diseases of the skin and mucous membranes |
| 12/11/2008 | WO2008128791A3 Progesterone-receptor antagonist for use in brca-mediated cancer alone or as combination with antiestrogen |
| 12/11/2008 | WO2008124522A3 Amylin formulations |
| 12/11/2008 | WO2008124009A3 Treating glaucoma |
| 12/11/2008 | WO2008111956A3 Fatty acid oxidation inhibitors treating hyperglycemia and related disorders |
| 12/11/2008 | WO2008110491A3 Chemotherapy of neoplastic diseases using combinations of rapamycin and compounds modulating mtor pathway alone or in combination with heat |
| 12/11/2008 | WO2008109560A3 Amelioration of cellular stress response |
| 12/11/2008 | WO2008102075A3 Novel therapeutic use for treating leukaemia |
| 12/11/2008 | WO2008085074A3 1, 3-dihydroimidazoles for treating cardiovascular disorders |
| 12/11/2008 | WO2008063603A3 Methods, compositions, and kits for treating pain and pruritis |
| 12/11/2008 | WO2008013989A8 Methods and compositions for identifying a cellular immune response against prostate cancer |
| 12/11/2008 | WO2008002905A3 Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same |
| 12/11/2008 | WO2007116029A3 Combination comprising a) a pyrimidylaminobenzamide compound, and b) a thr315lle kinase inhibitor |
| 12/11/2008 | WO2007111958A3 Method and compositions for potentiating pharmaceuticals with amino acid based medical foods |
| 12/11/2008 | WO2005046562A3 Use of sulfated hyaluronic acid |
| 12/11/2008 | US20080306143 Cathechins for the Treatment of Fibrillogenesis in Alzheimer's Disease, Parkinson's Disease, Systemic AA Amyloidosis, and Other Amyloid Disorders |
| 12/11/2008 | US20080306104 Tamper-resistant oral opioid agonist formulations |
| 12/11/2008 | US20080306103 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 12/11/2008 | US20080306085 Non-imidazole aryloxyalkylamines |
| 12/11/2008 | US20080306081 Combinations of Nicotinic Acetylcholine Alpha 7 Receptor Antagonists |
| 12/11/2008 | US20080306073 Antitumor Effect Potentiator, Antitumor Preparation, and Method for Treating Cancer |
| 12/11/2008 | US20080306043 Sabcomeline Alone or Combined with a Mood Stabilising or Antimanic Agent to Treat Bipolar Disorders |
| 12/11/2008 | US20080306005 Treatment of bone disorders with skeletal anabolic drugs |